Literature DB >> 36254142

Achalasia as an Unusual Cause of Acute Cellular Rejection of a Transplanted Heart.

Amanda Fernandes1, Crystal Lihong Yan1, Phillip Ruiz2, Nina Thakkar Rivera3.   

Abstract

A 68-year-old female with end-stage heart failure presented to the hospital for heart transplant. She was diagnosed with achalasia 14 months prior and treated with frequent botulinum toxin injections. She underwent orthotopic heart transplant on the day of admission and was extubated a few days later. She developed intractable nausea and vomiting. Her first endomyocardial biopsy revealed moderate, approaching severe rejection. She was treated with high-dose intravenous pulse steroids. Fluoroscopy at the time of follow-up biopsy showed undigested pills in her esophagus with narrowing at the distal end and thus failure to deliver immunosuppressive therapy. This case highlights achalasia as an etiology for acute rejection and its potential management.
Copyright © 2022 Amanda Fernandes et al.

Entities:  

Year:  2022        PMID: 36254142      PMCID: PMC9569230          DOI: 10.1155/2022/2054727

Source DB:  PubMed          Journal:  Case Rep Cardiol        ISSN: 2090-6404


  9 in total

Review 1.  Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs.

Authors:  JoAnn Lindenfeld; Geraldine G Miller; Simon F Shakar; Ronald Zolty; Brian D Lowes; Eugene E Wolfel; Luisa Mestroni; Robert L Page; Jon Kobashigawa
Journal:  Circulation       Date:  2004-12-14       Impact factor: 29.690

Review 2.  Current status of achalasia management: a review on diagnosis and treatment.

Authors:  Joshua Tuason; Haruhiro Inoue
Journal:  J Gastroenterol       Date:  2017-02-10       Impact factor: 7.527

Review 3.  Heart Transplant and Mechanical Circulatory Support in Patients With Advanced Heart Failure.

Authors:  Cristina Sánchez-Enrique; Ulrich P Jorde; José González-Costello
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2017-02-07

4.  Botulinum toxin for the treatment of hypercontractile esophagus: Results of a double-blind randomized sham-controlled study.

Authors:  François Mion; Sophie Marjoux; Fabien Subtil; Mathieu Pioche; Jerome Rivory; Sabine Roman; Frank Zerbib
Journal:  Neurogastroenterol Motil       Date:  2019-04-11       Impact factor: 3.598

5.  Incidence, morbidity and mortality of patients with achalasia in England: findings from a study of nationwide hospital and primary care data.

Authors:  Krishnarajah Nirantharakumar; Nigel J Trudgill; Philip R Harvey; Tom Thomas; Joht S Chandan; Jemma Mytton; Ben Coupland; Neeraj Bhala; Felicity Evison; Prashant Patel
Journal:  Gut       Date:  2018-06-20       Impact factor: 23.059

Review 6.  Medium and long-term outcomes after pneumatic dilation or laparoscopic Heller myotomy for achalasia: a meta-analysis.

Authors:  Cynthia E Weber; Christopher S Davis; Holly J Kramer; Jeff T Gibbs; Lourdes Robles; Piero Marco Fisichella
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2012-08       Impact factor: 1.719

7.  Gastrointestinal complications in heart transplant patients: MITOS study.

Authors:  B Díaz; F González Vilchez; L Almenar; J F Delgado; N Manito; M J Paniagua; M G Crespo; E Kaplinsky; D A Pascual; J Fernández-Yáñez; S Mirabet; J Palomo
Journal:  Transplant Proc       Date:  2007-09       Impact factor: 1.066

Review 8.  Percutaneous endoscopic gastrostomy: indications, technique, complications and management.

Authors:  Ata A Rahnemai-Azar; Amir A Rahnemaiazar; Rozhin Naghshizadian; Amparo Kurtz; Daniel T Farkas
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

9.  Impaired Esophageal Motility and Clearance Post-Lung Transplant: Risk For Chronic Allograft Failure.

Authors:  Anupong Tangaroonsanti; Augustine S Lee; Michael D Crowell; Marcelo F Vela; Daryl R Jones; David Erasmus; Cesar Keller; Jorge Mallea; Francisco Alvarez; Cristina Almansa; Kenneth R DeVault; Lesley A Houghton
Journal:  Clin Transl Gastroenterol       Date:  2017-06-29       Impact factor: 4.488

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.